Browsing Tag
Bhushan Akshikar
1 post
GSK India delivers 32% profit surge—Zejula and Jemperli launches set to transform cancer care
GSK India reports 32% PAT growth in FY25; read how oncology launches and vaccine growth are shaping the company’s future outlook.